Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosducin-like 3 pseudogene 7 (PDCL3P7) is a processed pseudogene that originated from the phosducin-like 3 (PDCL3) gene via retrotransposition. Pseudogenes like PDCL3P7 do not code for functional proteins due to disrupted open reading frames and other mutations, although in rare cases, some pseudogenes have regulatory roles at the RNA level[1][4]. There is no evidence that PDCL3P7 acts as a receptor, enzyme, transporter, transcription factor, or other molecular target class. To date, no studies have linked PDCL3P7 specifically to disease, drug response, or any canonical biological function. Its parent gene, PDCL3, functions as a chaperone protein and has been implicated in angiogenesis, protein folding, and cancer stem cell biology, but these features do not extend to the pseudogene itself[2][3]. No drugs, mechanisms of action, or safety concerns are reported for PDCL3P7.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosducin-like 3 pseudogene 7 (PDCL3P7).